( MENAFN ) Researchers from Australia and the United States have developed an innovative artificial intelligence tool that significantly accelerates and improves the accuracy of brain tumor classification, according to a report published by the Voice of America website. Traditional methods for identifying brain tumors, while reliable, often require several weeks to yield results. This process, known as DNA methylation-based profiling, is not widely accessible in many hospitals worldwide.

To address these limitations, a collaborative team from the Australian National University and the US National Cancer Institute has devised a new predictive approach to DNA methylation, which serves as a regulatory switch for gene activity. This breakthrough enables brain tumors to be classified into 10 main categories using a deep learning model, a sophisticated artificial intelligence technology inspired by human neural processing. The system, named DEPLOY, utilizes pathological images—microscopic images of a patient's tissue—to perform its analysis.

The researchers emphasize that DEPLOY is designed to complement the initial diagnostic efforts of pathologists and clinicians. Tai Huang, a research fellow at the Australian National University, highlighted the efficiency of the AI tool, explaining that “the traditional technique is very time-consuming, often taking two to three weeks to produce results. For patients with high-grade brain tumors, rapid treatment is crucial, and this techn.